Tech Company Financing Transactions
Omniox Funding Round
Private investors joined a $4.7 million venture round for Omniox. The funding round was announced on 7/28/2016.
Transaction Overview
Company Name
Announced On
7/28/2016
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$4,708,814
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 29 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
75 Shoreway Rd. A
San Carlos, CA 94070
USA
San Carlos, CA 94070
USA
Phone
Website
Email Address
Overview
Omniox is a biotechnology company commercializing a revolutionary and proprietary technology for a broad range of clinical indications in cancer, cardiovascular disease, and trauma.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Cary
Co-Founder
Jonathan Winger
Controller
Julia Simmons
VP - Bus. Development
John Wesley
VP - R & D
Ana Krtolica
VP - Regulatory Affairs
Davis Bauman
Browse more venture capital transactions:
Prev: 7/28/2016: Big Health venture capital transaction
Next: 7/28/2016: EverFi venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs